COMMUNIQUÉS West-GlobeNewswire

Philips selected for ARPA-H program to advance AI-enabled robotic stroke care
26/08/2026
August 26, 2026 Philips receives up to US$33.7 million award from ARPA-H to expand access to AI-enabled robotic stroke care, supporting the program's goal of expanding access to specialized interventions Philips will [...]
Milestone Scientific Achieves Debt-Free Balance Sheet Through Debt-to-Equity Conversion by Three Directors
26/08/2026
Conversion of $465,000 in Debt Strengthens Stockholders’ Equity and Further Aligns Directors with Shareholders ROSELAND, N.J., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of [...]
Legato Emerges from Stealth with $12 Million in Funding to Pioneer a New Era of Hearing Devices with AI-Powered Hearing Glasses
26/08/2026
Poised to shake up the $15B global hearing device market with new technology that blends performance with design, Legato will debut its first product, Legato Frames, in the coming months BOSTON, Aug. 26, 2026 (GLOBE [...]
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
26/08/2026
-- For the first time, OB/GYNs within the UNC Health system will be able to offer women FemVue ® fertility evaluation and FemaSeed as a first-line treatment option -- ATLANTA, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Femasys [...]
9/11 Anniversary Nears and the Health Effects Are Still Emerging 25 Years Later
26/08/2026
World Trade Center Health Program Urges Those Exposed to 9/11 Toxins as Children or Young Adults to Learn Whether They Qualify for Specialized Care NEW YORK, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Twenty-five years after the [...]
Novonesis Expands U.S. Workforce Development Efforts to Build the Next Generation of Biomanufacturing Talent
26/08/2026
New Nebraska biotechnology program and scholarship build on education and workforce partnerships across Novonesis’ U.S. communities Blair, Nebraska, Aug. 26, 2026 (GLOBE NEWSWIRE) -- As the U.S. biotechnology sector [...]
BTT Medical Institute Launches First-in-Human Safety Clinical Trial Evaluating Induced Hyperthermia with the Computerized Brain-Guided Abreu BTT 700 Temperature Management System (TMS) Inspired by the Nobel Prize-recognized Malarial Fever Therapy
26/08/2026
Initial phase study marks the clinical evaluation of the Abreu BTT 700 TMS and its thermofebrile protocol, laying the foundation for future efficacy trials in the treatment of ALS and other neurodegenerative disorders [...]
FDA Grants Fast Track Designation to SOTIO’s SOT106 ADC for Soft Tissue Sarcoma Treatment, Accelerating Clinical Development
26/08/2026
SOT106 targets LRRC15, a clinically validated target broadly expressed across multiple sarcoma subtypes First-in-human study expected to begin this year, marking a key development milestone for SOT106 PRAGUE, Basel and [...]
Odyssey Therapeutics to Participate in Upcoming Investor Conferences
26/08/2026
BOSTON, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (Nasdaq: ODTX) (“Odyssey” or the “Company”), a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients [...]
BridgeBio Announces First Participant Dosed in ASCEND-ATTR, a Phase 3b/4 Study Evaluating the Long-Term Effects of Acoramidis on Disease Regression in ATTR-CM
26/08/2026
- The ASCEND-ATTR study builds on the Phase 3 ATTRibute-CM CMR substudy results previously shared here , which indicated treatment with acoramidis may improve cardiac structure and function with evidence of amyloid [...]
Eikon Therapeutics to Participate in Investor Conferences in September 2026
26/08/2026
MILLBRAE, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious [...]
MicrobiotiX Completes Sentinel Cohort of its First-in-human Clinical Trial of MP101 for Pneumonia
26/08/2026
Photo Caption: Dr. Dongeun Yong, CEO, gives a tour of MicrobiotiX’s GMP facility, where the clinical material being used in the MP101 trial was manufactured. SEOUL, South Korea, Aug. 26, 2026 (GLOBE NEWSWIRE) -- [...]
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
26/08/2026
Professor Marlies Wijsenbeek will give an oral presentation on the quality-of-life outcomes assessed by the LCQ from the Phase 2b CORAL trial of nalbuphine ER for the treatment of patients with IPF-related chronic cough [...]
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
26/08/2026
WALTHAM, Mass., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in the Wells Fargo [...]
Wellness Together and TadHealth Partner to Expand Student Behavioral Health Support Through CYBHI
26/08/2026
Partnership helps California schools and community-based organizations simplify CYBHI participation while expanding access to behavioral health services for students NEWPORT BEACH, Calif., Aug. 26, 2026 (GLOBE NEWSWIRE [...]
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors
26/08/2026
Doses first patient at 70 mCi dose of RV-01, the first radiopharmaceutical therapeutic developed in Company’s joint venture with MD Anderson Cancer Center SYDNEY, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Radiopharm [...]
Ligand to Participate in September Investor Conferences
26/08/2026
JUPITER, Fla., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced its senior management team will participate in the following upcoming investor conferences: Wells Fargo [...]
INmune Bio Advances Ebstrocel™ Toward European Marketing Authorization with EMA Regulatory Filings
26/08/2026
Orphan Drug Designation application and pre-MAA Scientific Advice package submitted for Ebstrocel™ in RDEB Filings support a planned EU MAA in Q1 2027; orphan designation, if granted and maintained through approval, may [...]
Daré Bioscience’s Sildenafil Cream Data in Postmenopausal Women Published in Menopause - The Journal of The Menopause Society
26/08/2026
Daré’s proprietary formulation of topical sildenafil cream, 3.6% was well tolerated across all evaluated doses in the clinical study, with minimal systemic exposure Company continues activities necessary to advance its [...]

Pages